Eargo Inc. (EAR): Price and Financial Metrics


Eargo Inc. (EAR): $0.56

0.06 (+11.60%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

EAR POWR Grades

  • EAR scores best on the Growth dimension, with a Growth rank ahead of 96.54% of US stocks.
  • EAR's strongest trending metric is Value; it's been moving down over the last 179 days.
  • EAR ranks lowest in Stability; there it ranks in the 0th percentile.

EAR Stock Summary

  • With a year-over-year growth in debt of 759.94%, EARGO INC's debt growth rate surpasses 97.47% of about US stocks.
  • In terms of volatility of its share price, EAR is more volatile than 97.85% of stocks we're observing.
  • EARGO INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -367.62%, greater than the shareholder yield of merely 1.58% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to EARGO INC are QUOT, BIOC, KRMD, UDMY, and AUPH.
  • EAR's SEC filings can be seen here. And to visit EARGO INC's official web site, go to eargo.com.

EAR Valuation Summary

  • In comparison to the median Healthcare stock, EAR's EV/EBIT ratio is 101.32% lower, now standing at -0.1.
  • Over the past 25 months, EAR's price/sales ratio has gone down 29.3.

Below are key valuation metrics over time for EAR.

Stock Date P/S P/B P/E EV/EBIT
EAR 2022-11-01 6.8 2.2 -0.1 -0.1
EAR 2022-10-31 7.2 2.3 -0.1 -0.1
EAR 2022-10-28 7.0 2.3 -0.1 -0.1
EAR 2022-10-27 7.0 2.3 -0.1 -0.1
EAR 2022-10-26 7.1 2.3 -0.1 -0.1
EAR 2022-10-25 7.4 2.4 -0.1 -0.1

EAR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • EAR has a Quality Grade of D, ranking ahead of 9.8% of graded US stocks.
  • EAR's asset turnover comes in at 0.45 -- ranking 106th of 186 Medical Equipment stocks.
  • 500 - Internal server error

The table below shows EAR's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.450 0.710 -3.415
2020-12-31 0.532 0.684 -4.861

EAR Price Target

For more insight on analysts targets of EAR, see our EAR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $55.33 Average Broker Recommendation 2 (Hold)

EAR Stock Price Chart Interactive Chart >

Price chart for EAR

EAR Price/Volume Stats

Current price $0.56 52-week high $8.55
Prev. close $0.50 52-week low $0.48
Day low $0.48 Volume 1,353,000
Day high $0.58 Avg. volume 3,901,144
50-day MA $0.80 Dividend yield N/A
200-day MA $2.12 Market Cap 21.99M

Eargo Inc. (EAR) Company Bio


Eargo, Inc. develops next generation hearing aids and headsets solutions. It offers Eargomax, a new chip for maximum audio fidelity and noise reduction and Eargoplus a superior hearing technology designed for first time hearing aid users. The company was founded by Florent Michel, Raphael Michel and Daniel Shen on November 12, 2010 and is headquartered in San Jose, CA.


EAR Latest News Stream


Event/Time News Detail
Loading, please wait...

EAR Latest Social Stream


Loading social stream, please wait...

View Full EAR Social Stream

Latest EAR News From Around the Web

Below are the latest news stories about EARGO INC that investors may wish to consider to help them evaluate EAR as an investment opportunity.

Important Reminder for Eargo Stockholders of Record as of October 24, 2022

DEADLINE TO PARTICIPATE IN EARGO RIGHTS OFFERING IS TOMORROW, NOVEMBER 17, 2022: FOR U.S. HOLDERS WHO HOLD SHARES THROUGH A BROKERAGE ACCOUNT: 2:15 P.M., NEW YORK CITY TIME, ON NOVEMBER 17, 2022, SUBJECT TO ANY OTHER DEADLINES SET BY YOUR BROKER FOR U.S. REGISTERED HOLDERS: 5:00 P.M., NEW YORK CITY TIME, ON NOVEMBER 17, 2022 Eargo stockholders should contact Morrow Sodali, Eargo’s information agent for the rights offering, for assistance in participating in the rights offering by calling (800) 6

Yahoo | November 16, 2022

Eargo Third Quarter 2022 Earnings: US$1.29 loss per share (vs US$2.02 loss in 3Q 2021)

Eargo ( NASDAQ:EAR ) Third Quarter 2022 Results Key Financial Results Net loss: US$50.6m (loss narrowed by 36% from 3Q...

Yahoo | November 9, 2022

Eargo Announces Issuance of Quarterly Report for Third Fiscal Quarter

SAN JOSE, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (“Eargo” or the “Company”) (NASDAQ: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced the filing of Eargo’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022 (the “Form 10-Q”). On October 31, 2022, Eargo announced the launch of a rights offering of an aggregate of 375,000,000 shares of common stock at a subscription price of $0.50 pe

Yahoo | November 7, 2022

Eargo Now Available for Purchase in ~1,500 Victra Wireless Stores Nationwide

Eargo Announces Partnership with Victra, one of America’s Largest Wireless Retailers, for In-Person Retail Experience Across the Country In-store Display In-store Display SAN JOSE, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life for people with hearing loss, today announced the availability of Eargo in approximately 1,500 Victra Wireless stores across the country through a partnership between the companies.

Yahoo | November 3, 2022

Eargo Reports Third Quarter 2022 Financial Results

Third Quarter 2022 Highlights: Net revenues of $7.9 million, compared to ($22.9) million in the prior year periodGross systems shipped of 5,156, compared to 13,117 in the prior year periodReturn accrual rate of 32.3%, compared to 46.4% in the prior year periodGAAP gross margin of 24.0%; non-GAAP gross margin of 24.5%GAAP sales and marketing expense as a percent of net revenues of 142.7%; non-GAAP sales and marketing expense as a percent of net revenues of 134.5%Cash and cash equivalents of $88.1

Yahoo | November 3, 2022

Read More 'EAR' Stories Here

EAR Price Returns

1-mo -13.18%
3-mo -71.28%
6-mo -63.87%
1-year -90.12%
3-year N/A
5-year N/A
YTD -89.02%
2021 -88.62%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7209 seconds.